Emfizatamab is a monoclonal antibody designed to target CD19, CD3E, TNFRSF9, and PD-L1. This multifunctional antibody facilitates the engagement of immune effector cells with cancer cells, potentially enhancing the immune response against malignant cells. It is primarily used in research focused on the mechanisms of immune modulation in oncology and the therapeutic potential in various cancers.
Emfizatamab is a monoclonal antibody designed to target CD19, CD3E, TNFRSF9, and PD-L1. This multifunctional antibody facilitates the engagement of immune effector cells with cancer cells, potentially enhancing the immune response against malignant cells. It is primarily used in research focused on the mechanisms of immune modulation in oncology and the therapeutic potential in various cancers.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: